XENETIC BIOSCIENCES, INC. Accrued Liabilities, Current
XENETIC BIOSCIENCES, INC. (XBIO) had Accrued Liabilities, Current of $709.92 thousand as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-03-12
- 2025-12-31: Accrued Liabilities, Current $709.92K.
- 2024-12-31: Accrued Liabilities, Current $610.65K.
- 2023-12-31: Accrued Liabilities, Current $568.75K.
- 2022-12-31: Accrued Liabilities, Current $785.80K.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2025-12-31 | $709.92K 10-K · filed 2026-03-12 |
| 2024-12-31 | $610.65K 10-K · filed 2026-03-12 |
| 2023-12-31 | $568.75K 10-K · filed 2025-03-18 |
| 2022-12-31 | $785.80K 10-K · filed 2024-03-21 |
| 2021-12-31 | $1.03M 10-K · filed 2023-03-22 |
| 2021-09-30 | $873.01K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $653.13K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $590.38K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $574.05K 10-K · filed 2022-03-22 |
| 2019-12-31 | $463.99K 10-K · filed 2021-03-16 |
| 2018-12-31 | $664.03K 10-K · filed 2020-03-26 |
| 2018-09-30 | $800.38K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $796.16K 10-Q · filed 2018-08-10 |
| 2018-03-31 | $826.55K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $1.14M 10-K · filed 2019-03-29 |
| 2017-09-30 | $1.11M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $920.31K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $605.09K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $838.89K 10-K · filed 2018-03-30 |
| 2016-09-30 | $1.49M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $1.61M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $1.54M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $1.49M 10-K · filed 2017-03-31 |
| 2015-09-30 | $1.38M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $862.11K 10-Q · filed 2015-08-19 |
| 2015-03-31 | $935.03K 10-Q · filed 2015-05-20 |
| 2014-12-31 | $1.41M 10-K · filed 2016-03-30 |
| 2014-09-30 | $752.94K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $792.93K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $1.09M 10-Q · filed 2014-05-20 |
| 2013-12-31 | $1.83M 10-K · filed 2015-07-20 |
| 2012-12-31 | $456.74K 10-K · filed 2015-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |